Tenet Healthcare (THC) Is Back In Focus, What Is The Market Weighing?
Tenet Healthcare (THC) moved into focus after its latest earnings report showed higher quarterly and nine month sales and net income, along with a raised full year earnings outlook that signals management confidence.
That stronger earnings story has been backed up in the market, with Tenet Healthcare’s share price up 45.54% year to date and the latest close at $290.27, while its 1 year total shareholder return of 46.36% and very large 3 year and 5 year total shareholder returns point to momentum that has been building, rather than fading.
Compare Tenet Healthcare’s sharp earnings reset and strong share price momentum with a curated list of other companies showing similar strength in our 35 high quality undervalued stocks.
After a near 46% one year return and a recent jump in earnings guidance, Tenet Healthcare still trades below both analyst targets and one intrinsic value estimate. Is that a potential mispricing or a fair warning signal from the market?
Most Popular Narrative: 7% Overvalued
Tenet Healthcare closed at $290.27, while the bearish analyst Narrative on Simply Wall St assigns a fair value of $271.10 based on a 7.6% discount rate.
The current numbers and guidance imply that Tenet Healthcare’s share price already reflects a fairly valued, bearish skew where execution on high-acuity growth and cost programs needs to hold up just to justify the present valuation.
The bearish analysts are assuming Tenet Healthcare's revenue will grow by 2.1% annually over the next 3 years.
See why 1 investors see Tenet Healthcare as 7% overvalued.
Result: Fair Value of $271.10 (OVERVALUED)
Still, Tenet Healthcare’s reliance on higher acuity outpatient procedures and the Conifer restructuring means that any stumble on volumes or collections could quickly challenge this fair value view.
Find out about the key risks to this Tenet Healthcare narrative.
Another View: Tenet Healthcare Looks Cheap On Earnings
Seen through the bearish fair value of $271.10, Tenet Healthcare screens as 7% overvalued. Look at the P/E though and you get a very different picture. The stock trades on roughly 8x earnings, against a US Healthcare sector average of 25.3x and a peer group around 21.2x.
The fair ratio points to 17.7x as a level the market could move towards over time, which is more than double today’s multiple. That kind of gap can either reflect real concern about earnings risk or an opening for investors who think the profit reset and one off items are already priced in.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Skeptical about whether Tenet Healthcare is attractively priced or already stretched? Act quickly, review the underlying numbers, and weigh both sides of the story with 3 key rewards and 4 important warning signs.
Looking for more investment ideas beyond Tenet Healthcare?
If Tenet Healthcare has your attention, do not stop here. Broaden your watchlist with fresh ideas that focus on value, resilience, and long term staying power.
- Target potential mispricing by scanning for quality companies that still look overlooked using the 35 high quality undervalued stocks.
- Prioritize staying power and financial strength by filtering for firms with robust fundamentals through the list of solid balance sheet and fundamentals (24 results).
- Explore companies with the potential to become leaders over time by reviewing the 20 high quality undiscovered gems.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com